NK cells blur the frontier between innate and acquired immunity

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Terrazzano, Giuseppe ^a,b   Carbone, Ennio ^c,d  

^a UNIVERSITY OF BASILICATA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874252815     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00400     Document Type: Article

References (47)

1. Ardolino, M., Zingoni, A., Cerboni, C., Cecere, F., Soriani, A., Iannitto, M. L., et al. (2011). DNAM-1 ligand expression on Ag stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response:relevance for NK-T cell interaction. Blood 117, 4778-4786.
2. Bajénoff, M., Breart, B., Huang, A. Y., Qi, H., Cazareth, J., Braud, V. M., et al. (2006). Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203, 619-631.
3. Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., et al. (2006). Regulatory CD56 (bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103, 5941-5946.
4. Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., et al. (2011). Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208, 13-21.
5. Bryceson, Y. T., Ljunggren, H.G., and Long, E. O. (2009). Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 114,2657-2666.
6. Caligiuri, M. A. (2008). Human natural killer cells. Blood 112,461-469.
7. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., et al. (1997). A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
8. Carbone, E., Terrazzano, G., Meliàn, A., Zanzi, D., Moretta, L., Porcelli, S., et al. (2000). Inhibition of human NK cell mediated killing by CD1 molecules.J. Immunol. 164, 6130-6137.
9. Carbone, E., Terrazzano, G., Ruggiero, G., Zanzi, D., Ottaiano, A., Manzo, C., et al. (1999). Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29, 4022-4029.
10. Cella, M., Otero, K., and Colonna, M. (2010). Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. U.S.A. 107, 10961-10966.
11. Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T., and Spits, H. (2010). Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J.Exp. Med. 207, 281-290.
12. Cupedo, T., Crellin, N. K., Papazian, N., Rombouts, E. J., Weijer, K., Grogan, J. L., et al. (2009). Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+CD127+ natural killer-like cells. Nat. Immunol. 10, 66-74.
13. Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., et al. (2011). A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK cell survival and development. Blood 117, 1565-1573.
14. Eller, M. A., Koehler, R. N., Kijak, G. U., Eller, L. A., Guwatudde, D., Marovich, M. A., et al. (2011). Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunction-ality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif. J. Virol. 85,4802-4811.
15. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., and Munz, C. (2002). Human dendritic cells activate resting Nk cells and are recognized via the NKp30 receptor by activated NK cells.J. Exp. Med. 195, 343-351.
16. Gleimer, M., and Parham, P. (2003). Stress management: MHC class I and class I like molecules as reporters of cellular stress. Immunity 19, 469-477.
17. Jaeger, B. N., Donadieu, J., Cognet, C., Bernat, C., Ordoñez-Rueda, D., Barlogis, V., et al. (2012). Neutrophil depletion impairs natural killer cell maturation, function and homeostasis. J. Exp. Med. 209, 565-580.
18. Kärre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. (1986). Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
19. Kiessling, R., Klein, E., and Wigzell, H. (1975). Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112-117.
20. Kuwano, K., Arai, S., Munakata, T., Tomita, Y., Yoshitake, Y., and Kumagai, K. J. (1986). Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.J. Immunol. 137, 1462-1468.
21. Lanier, L. L. (2005). NK cell recognition. Annu. Rev. Immunol. 23, 225-274.
22. Li, Z., Lim, W. K., Mahesh, S. P., Liu, S., and Nussenblatt, R. B. (2005). Cutting edge: in vivo blockade of human IL-2receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J. Immunol. 174, 5187-5191.
23. Ljunggren, H. G., and Malmberg, K. J. (2007). Prospects for the use of NK cells in immunother-apy of human cancer. Nat. Rev. Immunol. 7, 329-339.
24. Lopez-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., et al. (2011). Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 108, 14725-14732.
25. Lunemann, A., Lunemann, J. D., and Munz, C. (2009). Regulatory NK-cell functions in inflammation and autoimmunity. Mol. Med. 15, 352-358.
26. Luszczek, W., Mañczak, M., Cisło, M., Nockowski, P., Wisniewski, A., Jasek, M., et al. (2004). Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum. Immunol. 65, 758-766.
27. Martin, M. P., Nelson, G., Lee, J.H., Pellett, F., Xiaojiang, G., Wade, J., et al. (2002). Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Iglike receptor genes in the absence of specific HLA-C alleles.J. Immunol. 169, 2818-2822.
28. Martín-Fontecha, A., Assarsson, E., Carbone, E., Kärre, K., and Ljunggren, H. G. (1999). Triggering of murine NK cells by CD40 and CD86 (B7-2). J. Immunol. 162, 5910-5916.
29. Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., and Sallusto, F. (2004). Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 12, 1260-1265.
30. Momot, T., Kock, S., Hunzelmann, N., Krieg, T., Ulbricht, K., Schmidt, R. E., et al. (2004). Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 50, 1561-1565.
31. Moretta, A. (2002). Natural killer cells and dendritic cells:randezvous in abused tissues. Nat. Rev. Immunol. 2, 957-964.
32. Ogasawara, K., Hamerman, J. A., Ehrlich, L. R., Bour-Jordan, H., Santamaria, P., Bluestone, J. A., et al. (2004). NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757-767.
33. Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., et al. (2003). Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41-51.
34. Parham, P. (2005). MHC Class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5,201-214.
35. Paust, S., Senman, B., and von Andrian, U. H. (2010). Adaptive immune responses mediated by natural killer cells. Immunol. Rev. 235, 286-296.
36. Procopio, A. D., Allavena, P., and Ortaldo, J. R. (1985). Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF). J. Immunol. 135, 3264-3271.
37. Ruggiero, G., Sica, M., Luciano, L., Savoia, F., Cosentini, E., Alfinito, F., et al. (2009). A case of myelodysplastic syndrome associated with CD14(+)CD56(+) monocytosis, expansion of NK lymphocytes and defect of HLA-E expression. Leuk.Res. 33, 181-185.
38. Salazar-Mather, T. P., Orange, J. S., and Biron, C. A. (1998). Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent Pathways. J. Exp. Med. 187, 1-14.
39. Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., et al. (2004). Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 122, 1133-1136.
40. Terrazzano, G., Alfinito, F., Palatucci, A. T., Rubino, V., Pepa, R. D., Giovazzino, A., et al. (2012). HLA-E and HLA class I molecules on bone marrow and peripheral blood polymorphonu-clear cells of myelodysplatic patients. Leuk. Res. doi: 10.1016/j.leukres.2012.09.015 [Epub ahead of print].
41. Terrazzano, G., Sica, M., Gianfrani, C., Mazzarella, G., Maurano, F., De Giulio, B., et al. (2007). Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J. Immunol. 179, 372-381.
42. Terrazzano, G., Zanzi, D., Palomba, C., Carbone, E., Grimaldi, S., Pisanti, S., et al. (2002). Differential involvement of CD40, CD80, and major histocom-patibility complex class I molecules in cytotoxi-city induction and interferon-gamma production by human natural killer effectors. J. Leukoc. Biol. 72,305-311.
43. Tovar, Z., Pope, R. M., and Talal, N. (1986). Modulation of spontaneous immunoglob-ulin production by natural killer cells in rheumatoid arthritis. Arthritis Rheum. 29, 1435-1439.
44. Velardi, A. (2012). Natural killer cell alloreactiv-ity 10 years later. Curr. Opin. Hematol. 19, 421-426.
45. Vivier, E., and Anfossi, N. (2004). Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4, 190-198.
46. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S. (2008). Functions of natural killer cells. Nat. Immunol. 5, 503-510.
47. Wyatt, R. M., and Dawson, J. R. (1991). Ig production Characterization of a subset of human B lymphocytes interacting with natural killer cells. J. Immunol. 147, 3381-3388.